Curis (CRIS) Shares Outstanding (Weighted Average) (2010 - 2026)

Curis (CRIS) reported Shares Outstanding (Weighted Average) of $19.4 million for Q1 2026, up 127.97% on a YoY basis from $8.5 million in Q1 2025, and up 47.09% quarter-over-quarter from $13.2 million in Q4 2025.

Curis (CRIS) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends

Curis has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $19.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 127.97% year-over-year to $19.4 million; the trailing twelve-month figure through Mar 2026 stood at $19.4 million (up 127.97% YoY), and the FY2025 full-year result was $13.2 million, up 108.74% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $19.4 million, up from $13.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $91.6 million in Q2 2022, with the low at $4.7 million in Q4 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $18.0 million across 5 years, with a median of $5.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) slumped 94.9% — and 2025, when it surged 168.13%.
  • Curis' Shares Outstanding (Weighted Average) stood at $4.7 million in 2022, then climbed by 13.36% to $5.3 million in 2023, then advanced by 19.14% to $6.3 million in 2024, then jumped by 108.74% to $13.2 million in 2025, then surged by 47.09% to $19.4 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $19.4 million (Q1 2026), $13.2 million (Q4 2025), and $15.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 185,491.37 Bn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 4,489.46 Bn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 100.00 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 118.76 Bn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 417.01 Bn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 254.10 Mn
9 Abivax 95.45 Bn 95.45 Bn - 928.40 Mn
10 Curis 8.58 Mn -6.42 Mn - 19.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.36 Mn
Dec 31, 2025 13.16 Mn
Sep 30, 2025 15.68 Mn
Jun 30, 2025 12.63 Mn
Mar 31, 2025 8.49 Mn
Dec 31, 2024 6.31 Mn
Sep 30, 2024 5.85 Mn
Jun 30, 2024 5.80 Mn
Mar 31, 2024 5.78 Mn
Dec 31, 2023 5.29 Mn
Sep 30, 2023 5.13 Mn
Jun 30, 2023 4.83 Mn
Mar 31, 2023 4.83 Mn
Dec 31, 2022 4.67 Mn
Sep 30, 2022 4.69 Mn
Jun 30, 2022 91.65 Mn
Mar 31, 2022 91.65 Mn
Dec 31, 2021 91.57 Mn
Sep 30, 2021 91.55 Mn
Jun 30, 2021 91.53 Mn